Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Recomendações importantes para tratamento do câncer da NCCN estão agora disponíveis em francês, alemão, italiano, português, russo e espanhol
  • Latin America - español
  • USA - Pусский
  • USA - Français
  • USA - Deutsch
  • USA - Polski
  • USA - español
  • USA - čeština
  • India - English
  • USA - slovenčina
  • USA - English

NCCN Logo (C)NCCN(R) 2018. All rights reserved.

News provided by

National Comprehensive Cancer Network

Sep 03, 2020, 07:45 ET

Share this article

Share toX

Share this article

Share toX

Diretrizes de prática clínica padrão ouro em oncologia foram traduzidas para permitir maior acesso global e estão disponíveis gratuitamente on-line em   NCCN.org/global.

PLYMOUTH MEETING, Pensilvânia, 3 de setembro de 2020 /PRNewswire/ -- A National Comprehensive Cancer Network® (NCCN®) anunciou hoje que versões em vários idiomas das diretrizes da NCCN, NCCN Guidelines® estão disponíveis, além de todo o material em inglês, para vários tipos de câncer de alta incidência. As recomendações de especialistas em francês, alemão, italiano, português, russo e espanhol podem ser acessadas gratuitamente no site NCCN.org/global ou na Biblioteca Virtual gratuita do aplicativo NCCN Guidelines®.

Continue Reading
Traduções das Diretrizes da NCCN (NCCN Guidelines®) estão disponíveis gratuitamente no site  NCCN.org/global ou na Biblioteca Virtual do aplicativo NCCN Guidelines®.
Traduções das Diretrizes da NCCN (NCCN Guidelines®) estão disponíveis gratuitamente no site NCCN.org/global ou na Biblioteca Virtual do aplicativo NCCN Guidelines®.

A NCCN se dedica a definir e promover em todo o mundo o tratamento do câncer de alta qualidade, de grande valor e centrado no paciente. As diretrizes da NCCN constituem o padrão reconhecido para políticas e orientação para o tratamento do câncer e as diretrizes de prática clínica mais completas e frequentemente atualizadas disponíveis em qualquer área da medicina. Elas são formuladas por tema, por painéis interdisciplinares de especialistas de 30 importantes centros para tratamento de câncer nos Estados Unidos.

"A NCCN tem o compromisso de manter e ampliar uma biblioteca de recursos globais para garantir que os profissionais de saúde e os pacientes tenham acesso aos padrões mais atualizados para o tratamento do câncer em todo o mundo", disse o presidente executivo da NCCN, Dr. Robert W. Carlson. "Quase metade dos nossos usuários registrados moram fora dos Estados Unidos e muitos podem se sentir mais confortáveis com idiomas que não sejam o inglês; as Diretrizes da NCN foram baixadas em mais de 180 países. Aumentar o número de traduções a partir do inglês permite um maior acesso a essas informações cruciais em toda a Europa e em outras partes do mundo."

As Diretrizes da NCCN recentemente traduzidas abrangem os seguintes tipos de câncer:

  • Leucemia mieloide aguda (LMA) – português e espanhol
  • Linfomas de células B – francês, alemão, italiano e espanhol
  • Câncer de mama – espanhol
  • Leucemia linfocítica crônica/linfoma linfocítico de pequenas células (LLC/LLPC) – português e espanhol
  • Câncer de cólon – espanhol
  • Câncer de estômago – espanhol
  • Leucemia de células pilosas – italiano e espanhol
  • Câncer de cabeça e pescoço – espanhol
  • Linfoma de Hodgkin – italiano e espanhol
  • Melanoma (cutâneo) – espanhol
  • Mieloma múltiplo – português e espanhol
  • Câncer de pulmão de células não pequenas – italiano e espanhol
  • Linfomas cutâneos primários – italiano e espanhol
  • Linfomas de células T – italiano e espanhol

A NCCN oferece também diretrizes de suporte para tratamento, inclusive na versão em russo das Diretrizes da NCCN para Gestão de Toxicidades imunorrelacionadas, que cobrem eventos adversos imunorrelacionados (irAEs) de inibidores de checkpoint imunológico e tratamento com células T do receptor de antígeno quimérico (CAR, em sua sigla em inglês). O Termômetro de Angústia da NCCN, uma ferramenta para medir e tratar do bem-estar psicossocial das pessoas com câncer, também foi traduzido para 46 idiomas, inclusive francês, alemão, italiano, português, russo e espanhol.

Além de todas essas recomendações para adultos com câncer, a NCCN anunciou recentemente também a tradução das Diretrizes da NCCN para Leucemia Linfoblástica Aguda Pediátrica para português e espanhol.

Visite NCCN.org/global/international_adaptations.aspx para acessar e baixar 24 adaptações globais e 230 traduções dos recursos da NCCN em 47 idiomas. A equipe global da NCCN oferece também versões com fácil interface para os pacientes em vários idiomas, inclusive tcheco, francês, alemão, italiano, russo e espanhol. A NCCN fornece a Estrutura da NCCN para Estratificação dos Recursos das Diretrizes da NCCN (NCCN Framework™) e as Diretrizes Harmonizadas da NCCN, NCCN Harmonized Guidelines™, que reúnem as melhores recomendações e métodos pragmáticos para o tratamento em ambientes com recursos limitados, como países de baia e média renda.

Participe dessa conversa on-line com o hashtag #NCCNGlobal.

Sobre a National Comprehensive Cancer Network
A National Comprehensive Cancer Network® (NCCN®) é uma aliança sem fins lucrativos dos principais centros de câncer dedicados ao tratamento de pacientes, pesquisa e educação. A NCCN se dedica a melhorar e promover o tratamento do câncer que seja de alta qualidade, eficaz, eficiente e acessível, para que os pacientes possam viver melhor. As Diretrizes de Prática Clínica da NCNC em oncologia (NCCN Clinical Practice Guidelines, NCCN Guidelines®) fornecem recomendações transparentes, baseadas em evidências e em consenso de especialistas, para tratamento do câncer, prevenção e serviços de apoio; elas constituem o padrão reconhecido para direção e políticas clínicas em controle do câncer e as diretrizes mais completas e frequentemente atualizadas de prática clínica disponíveis em qualquer área da medicina. As diretrizes para os pacientes NCCN Guidelines for Patients® fornecem informações de especialistas para tratamento do câncer, para instruir e capacitar pacientes e profissionais de saúde, através do apoio da NCCN Foundation®. A NCCN também promove  educação continuada, iniciativas globais, política e colaboração e publicações na área de oncologia. Visite NCCN.org para obter mais informações e siga a NCCN no Facebook @NCCNorg, Instagram @NCCNorg, e Twitter @NCCN.

Contato para a mídia:
Rachel Darwin
267-622-6624
[email protected]

Foto - https://mma.prnewswire.com/media/1246663/Newswire_Translation_Euro.jpg
Logo - https://mma.prnewswire.com/media/441768/NCCN_Logo.jpg

FONTE National Comprehensive Cancer Network

Related Links

www.nccn.org

21%

more press release views with 
Request a Demo

Modal title

Also from this source

New JNCCN Study Confirms it's 'Never Too Late' to See Survival Benefits from Quitting Smoking--Even With Late-Stage Cancer

New JNCCN Study Confirms it's 'Never Too Late' to See Survival Benefits from Quitting Smoking--Even With Late-Stage Cancer

New research published online in JNCCN—Journal of the National Comprehensive Cancer Network finds that people with cancer who quit smoking had a much ...

NCCN Guidelines Navigator for Breast Cancer Genetic Testing and Treatment Debuts During Breast Cancer Awareness Month

NCCN Guidelines Navigator for Breast Cancer Genetic Testing and Treatment Debuts During Breast Cancer Awareness Month

Today, the National Comprehensive Cancer Network® (NCCN®)—a nonprofit responsible for globally utilized guidelines for cancer care—is sharing new...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

New Products & Services

New Products & Services

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.